Breaking News

IBBR Seeks RFPs for cGMP Biologics Manufacturing

Facility is also equipped to perform process development research, preclinical manufacturing for IND-enabling tox studies, Point of Concept studies

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

The Institute for Bioscience and Biotechnology Research (IBBR) is seeking proposals to lease a biomanufacturing facility to produce biologics under cGMP conditions in compliance with FDA requirements for Phase I/II trials. The facility is also equipped to perform process development research, preclinical manufacturing for IND-enabling toxicology studies, Point of Concept (POC) studies, and process demonstration in advance of Good Manufacturing Practices (GMP) manufacturing. IBBR is a joint resea...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters